Berberine cooperates with adrenal androgen dehydroepiandrosterone sulfate to attenuate PDGF-induced proliferation of vascular smooth muscle cell A7r5 through Skp2 signaling pathway

Molecular and Cellular Biochemistry

Volumn 355, Issue 1-2, 2011, Pages 127-134

  Liu, Jia ^a   Xiu, Jian ^a   Cao, Junxian ^a   Gao, Qianping ^a   Ma, Dan ^a   Fu, Lu ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Berberine; Cell cycle arrest; DHEAS; Skp2

Indexed keywords

BERBERINE; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN E; CYCLINE; PLATELET DERIVED GROWTH FACTOR BB; PRASTERONE SULFATE; PROTEIN P27; S PHASE KINASE ASSOCIATED PROTEIN 2;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL ASSAY; CELL CYCLE ARREST; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN; CELL STRAIN A7R5; CONTROLLED STUDY; DRUG BINDING; DRUG EFFECT; DRUG POTENTIATION; GROWTH INHIBITION; IMMUNOPRECIPITATION; MOLECULAR WEIGHT; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; RESTENOSIS; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

ANIMALS; BERBERINE; CELL CYCLE CHECKPOINTS; CELL CYCLE PROTEINS; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DEHYDROEPIANDROSTERONE; DRUG SYNERGISM; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PLATELET-DERIVED GROWTH FACTOR; PROTEIN BINDING; RATS; S-PHASE KINASE-ASSOCIATED PROTEINS; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 80051550482     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-011-0846-x     Document Type: Article

References (41)

1. MW Liu GS Roubin SB King III 1989 Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia Circulation 79 6 1374 1387 2524293 10.1161/01.CIR.79.6.1374 1:STN:280:DyaL1M3kvFOhtw%3D%3D (Pubitemid 19155772)
2. HC Lowe SN Oesterle LM Khachigian 2002 Coronary in-stent restenosis: current status and future strategies J Am Coll Cardiol 39 2 183 193 11788206 10.1016/S0735-1097(01)01742-9 (Pubitemid 34084620)
3. MR Bennett 2003 In-stent stenosis: pathology and implications for the development of drug eluting stents Heart 89 2 218 224 12527687 10.1136/heart.89.2.218 (Pubitemid 36115115)
4. K Kawai-Kowase GK Owens 2007 Multiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cells Am J Physiol Cell Physiol 292 1 C59 C69 16956962 10.1152/ajpcell.00394.2006 1:CAS:528:DC%2BD2sXisFCrtLk%3D (Pubitemid 46127305)
5. K Uchida M Sasahara N Morigami F Hazama M Kinoshita 1996 Expression of platelet-derived growth factor B-chain in neointimal smooth muscle cells of balloon injured rabbit femoral arteries Atherosclerosis 124 1 9 23 8800490 10.1016/0021-9150(95)05742-0 1:CAS:528:DyaK28XjsVOhtLg%3D (Pubitemid 26188203)
6. B Chandrasekar JF Tanguay 2000 Platelets and restenosis J Am Coll Cardiol 35 3 555 562 10716455 10.1016/S0735-1097(99)00596-3 1:CAS:528: DC%2BD3cXitVCjsLk%3D (Pubitemid 30167011)
7. X Yang DP Thomas X Zhang BW Culver BM Alexander WJ Murdoch MN Rao DA Tulis J Ren N Sreejayan 2006 Curcumin inhibits platelet-derived growth factor-stimulated vascular smooth muscle cell function and injury-induced neointima formation Arterioscler Thromb Vasc Biol 26 1 85 90 16239599 10.1161/01.ATV.0000191635.00744.b6 (Pubitemid 43732232)
8. RK Assoian EE Marcantonio 1996 The extracellular matrix as a cell cycle control element in atherosclerosis and restenosis J Clin Invest 98 11 2436 2439 8958203 10.1172/JCI119059 1:CAS:528:DyaK28XnsVWhsbs%3D (Pubitemid 26415061)
9. N Orentreich JL Brind RL Rizer JH Vogelman 1984 Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood J Clin Endocrinol Metab 59 3 551 555 6235241 10.1210/jcem-59-3-551 1:CAS:528:DyaL2cXlsVCns7g%3D (Pubitemid 14031806)
10. PJ Hornsby 1995 Biosynthesis of DHEAS by the human adrenal cortex and its age-related decline Ann N Y Acad Sci 774 29 46 8597467 10.1111/j.1749-6632. 1995.tb17370.x 1:CAS:528:DyaK28XjtVCks78%3D (Pubitemid 26140358)
11. A Vermeulen 1995 Dehydroepiandrosterone sulfate and aging Ann N Y Acad Sci 774 121 127 8597452 10.1111/j.1749-6632.1995.tb17376.x 1:CAS:528: DyaK28XjtVCks7k%3D (Pubitemid 26140364)
12. LE Mitchell DL Sprecher IB Borecki T Rice PM Laskarzewski DC Rao 1994 Evidence for an association between dehydroepiandrosterone sulfate and nonfatal, premature myocardial infarction in males Circulation 89 1 89 93 8281699 1:STN:280:DyaK2c7gvFSluw%3D%3D (Pubitemid 24026476)
13. E Barrett-Connor D Goodman-Gruen 1995 The epidemiology of DHEAS and cardiovascular disease Ann N Y Acad Sci 774 259 270 8597464 10.1111/j.1749-6632. 1995.tb17386.x-i1 1:STN:280:DyaK287ntVentQ%3D%3D (Pubitemid 26140375)
14. J Słowínska-Srzednicka S Zgliczyński M Ciświcka-Sznajderman M Srzednicki P Soszyński M Biernacka M Woroszyłska W Ruzyłło Z Sadowski 1989 Decreased plasma dehydroepiandrosterone sulfate and dihydrotestosterone concentrations in young men after myocardial infarction Atherosclerosis 79 2-3 197 203 2532016 10.1016/0021-9150(89)90124-X (Pubitemid 19226328)
15. JM Peters YC Zhou PA Ram SS Lee FJ Gonzalez DJ Waxman 1996 Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate Mol Pharmacol 50 1 67 74 8700121 1:CAS:528:DyaK28XksVylsrk%3D (Pubitemid 26250076)
16. D Furutama R Fukui M Amakawa N Ohsawa 1998 Inhibition of migration and proliferation of vascular smooth muscle cells by dehydroepiandrosterone sulfate Biochim Biophys Acta 1406 1 107 114 9545554 1:CAS:528:DyaK1cXhtlOjtbo%3D (Pubitemid 28162316)
17. V Hampl J Bíbová V Povýsilová J Herget 2003 Dehydroepiandrosterone sulphate reduces chronic hypoxic pulmonary hypertension in rats Eur Respir J 21 5 862 865 12765434 10.1183/09031936.03.00084503 1:CAS:528:DC%2BD3sXktleru7s%3D (Pubitemid 36592298)
18. R Altman DD Motton RS Kota JC Rutledge 2008 Inhibition of vascular inflammation by dehydroepiandrosterone sulfate in human aortic endothelial cells: roles of PPARalpha and NF-kappaB Vascul Pharmacol 48 2-3 76 84 18255343 10.1016/j.vph.2007.12.002 1:CAS:528:DC%2BD1cXjtVWmsLc%3D
19. W Kong J Wei P Abidi M Lin S Inaba C Li Y Wang Z Wang S Si H Pan S Wang J Wu Y Wang Z Li J Liu JD Jiang 2004 Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins Nat Med 10 12 1344 1351 15531889 10.1038/nm1135 1:CAS:528:DC%2BD2cXhtVCisbfK (Pubitemid 40022716)
20. JP Hu K Nishishita E Sakai H Yoshida Y Kato T Tsukuba K Okamoto 2008 Berberine inhibits RANKL-induced osteoclast formation and survival through suppressing the NF-kappaB and Akt pathways Eur J Pharmacol 580 1-2 70 79 18083161 10.1016/j.ejphar.2007.11.013 1:CAS:528:DC%2BD1cXlt1egtA%3D%3D
21. S Lee HJ Lim HY Park KS Lee JH Park Y Jang 2006 Berberine inhibits rat vascular smooth muscle cell proliferation and migration in vitro and improves neointima formation after balloon injury in vivo. Berberine improves neointima formation in a rat model Atherosclerosis 186 1 29 37 16098530 10.1016/j.atherosclerosis.2005.06.048 1:CAS:528:DC%2BD28XjtFGltLw%3D
22. L Zhou Y Yang X Wang S Liu W Shang G Yuan F Li J Tang M Chen J Chen 2007 Berberine stimulates glucose transport through a mechanism distinct from insulin Metabolism 56 3 405 412 17292731 10.1016/j.metabol.2006.10.025 1:CAS:528:DC%2BD2sXhs1Clt7c%3D (Pubitemid 46209231)
23. JB Kim JH Yu E Ko KW Lee AK Song SY Park I Shin W Han DY Noh 2010 The alkaloid Berberine inhibits the growth of Anoikis-resistant MCF-7 and MDA-MB-231 breast cancer cell lines by inducing cell cycle arrest Phytomedicine 17 6 436 440 19800775 10.1016/j.phymed.2009.08.012 1:CAS:528:DC%2BC3cXot1Gntb0%3D
24. AC Carrano E Eytan A Hershko M Pagano 1999 SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27 Nat Cell Biol 1 4 193 199 10559916 10.1038/12013 1:CAS:528:DyaK1MXltlSjtr0%3D (Pubitemid 129500937)
25. H Sutterlüty E Chatelain A Marti C Wirbelauer M Senften U Müller W Krek 1999 p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells Nat Cell Biol 1 4 207 214 10559918 10.1038/12027 (Pubitemid 129500939)
26. K Nakayama H Nagahama YA Minamishima S Miyake N Ishida S Hatakeyama M Kitagawa S Iemura T Natsume KI Nakayama 2004 Skp2-mediated degradation of p27 regulates progression into mitosis Dev Cell 6 5 661 672 15130491 10.1016/S1534-5807(04)00131-5 1:CAS:528:DC%2BD2cXktlKrs74%3D (Pubitemid 38579350)
27. M Bond GB Sala-Newby AC Newby 2004 Focal adhesion kinase (FAK)-dependent regulation of S-phase kinase-associated protein-2 (Skp-2) stability. A novel mechanism regulating smooth muscle cell proliferation J Biol Chem 279 36 37304 37310 15208331 10.1074/jbc.M404307200 1:CAS:528:DC%2BD2cXntFSgtbo%3D (Pubitemid 39195437)
28. AC Carrano M Pagano 2001 Role of the F-box protein Skp2 in adhesion-dependent cell cycle progression J Cell Biol 153 7 1381 1390 11425869 10.1083/jcb.153.7.1381 1:CAS:528:DC%2BD3MXkslensL0%3D (Pubitemid 34286124)
29. Z Mai GL Blackburn JR Zhou 2007 Soy phytochemicals synergistically enhance the preventive effect of tamoxifen on the growth of estrogen-dependent human breast carcinoma in mice Carcinogenesis 28 6 1217 1223 17234721 10.1093/carcin/bgm004 1:CAS:528:DC%2BD2sXnt1Cmt7c%3D (Pubitemid 47062680)
30. D Wang Z Wang B Tian X Li S Li Y Tian 2008 Two hour exposure to sodium butyrate sensitizes bladder cancer to anticancer drugs Int J Urol 15 5 435 441 18452462 10.1111/j.1442-2042.2008.02025.x (Pubitemid 351623895)
31. TC Chou P Talalay 1984 Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors Adv Enzyme Regul 22 27 55 6382953 10.1016/0065-2571(84)90007-4 1:CAS:528: DyaL2cXktlaksLk%3D
32. GW Stone SG Ellis DA Cox J Hermiller C O'Shaughnessy JT Mann M Turco R Caputo P Bergin J Greenberg JJ Popma ME Russell TAXUS-IV Investigators 2004 A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease N Engl J Med 350 3 221 231 14724301 10.1056/NEJMoa032441 1:CAS:528: DC%2BD2cXkvVKmtQ%3D%3D (Pubitemid 38067635)
33. A Yoneyama Y Kamiya M Kawaguchi T Fujinami 1997 Effects of dehydroepiandrosterone on proliferation of human aortic smooth muscle cells Life Sci 60 11 833 838 9076322 10.1016/S0024-3205(97)00011-8 1:CAS:528: DyaK2sXhtlerur8%3D (Pubitemid 27153448)
34. P Saenger M New 1977 Inhibitory action of dehydroepiandrosterone (DHEA) on fibroblast growth Experientia 33 7 966 967 142647 10.1007/BF01951309 1:CAS:528:DyaE2sXkvFKnt74%3D (Pubitemid 8128864)
35. AW Meikle RW Dorchuck BA Araneo JD Stringham TG Evans SL Spruance RA Daynes 1992 The presence of a dehydroepiandrosterone-specific receptor binding complex in murine T cells J Steroid Biochem Mol Biol 42 3-4 293 304 1351401 10.1016/0960-0760(92)90132-3 1:CAS:528:DyaK38XksVSktb8%3D
36. M McIntosh D Hausman R Martin G Hausman 1998 Dehydroepiandrosterone attenuates preadipocyte growth in primary cultures of stromal-vascular cells Am J Physiol 275 2 Pt 1 E285 E293 9688631 1:CAS:528:DyaK1cXlsVCktrg%3D
37. AH Amin TV Subbaiah KM Abbasi 1969 Berberine sulfate: antimicrobial activity, bioassay, and mode of action Can J Microbiol 15 9 1067 1076 4906191 10.1139/m69-190 1:CAS:528:DyaF1MXkvF2hsLY%3D
38. WH Ko XQ Yao CW Lau WI Law ZY Chen W Kwok K Ho Y Huang 2000 Vasorelaxant and antiproliferative effects of berberine Eur J Pharmacol 399 2-3 187 196 10884519 10.1016/S0014-2999(00)00339-3 1:CAS:528:DC%2BD3cXksFGit7o%3D (Pubitemid 30407040)
39. K Collins T Jacks NP Pavletich 1997 The cell cycle and cancer Proc Natl Acad Sci USA 94 7 2776 2778 9096291 10.1073/pnas.94.7.2776 1:CAS:528: DyaK2sXisVKhu7k%3D (Pubitemid 27157209)
40. B Lee CH Kim SK Moon 2006 Honokiol causes the p21WAF1-mediated G(1)-phase arrest of the cell cycle through inducing p38 mitogen activated protein kinase in vascular smooth muscle cells FEBS Lett 580 22 5177 5184 16962592 10.1016/j.febslet.2006.08.064 1:CAS:528:DC%2BD28XpvFGnt74%3D (Pubitemid 44437592)
41. A Vidal A Koff 2000 Cell-cycle inhibitors: three families united by a common cause Gene 247 1-2 1 15 10773440 10.1016/S0378-1119(00)00092-5 1:CAS:528:DC%2BD3cXisV2ltbk%3D (Pubitemid 30201556)